← Eichor
Study identifier: NCT05374824 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

Condition: Lennox Gastaut Syndrome  ·  Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

PhaseN/A
Planned participants4680
Who can joinAll sexes, N/A to 26 Years
Healthy volunteersNo

About this study

Lennox-Gastaut syndrome is a serious and rare form of epilepsy that begins in infancy and early childhood. Seizures and their consequences need medical attention, emergency encounters, and hospitalizations. Seizures disrupt home life for the patient and for family. Lennox-Gastaut syndrome is typically accompanied by disabilities in motor, communication, eating, and other skills needed for daily function. Lennox-Gastaut syndrome (LGS) has no cure. Although current treatments may help reduce the number of seizures, none are expected to eliminate them entirely; these treatments are palliative. The main treatments include anti-seizure medications and some surgical approaches, including the implantation of a vagus nerve stimulator (a pacemaker-like generator implanted in the chest wall and programmed by a physician to stimulate the vagus nerve in the neck) and corpus callosotomy (cutting through the band of fibers that connect the two sides of the brain). While both types of treatment (medications and surgeries) produce some benefit by reducing how often the seizures occur, both also have some risks. All medications can, in some patients, produce moderate to severe side effects. This is true of anti-seizure medications. Most patients with LGS take several anti-seizure medications at a time. Surgeries can also have associated risks and is additionally stressful for parents and family members. Currently, there is no strong evidence to support parents and physicians in deciding whic…

This description comes directly from the study's public registry record.

Talk to the study team

Sandi Lam, MD MBA  ·  312 227 4220  ·  slam@luriechildrens.org

Marc Rosenman, MD  ·  312 227 4220  ·  mrosenman@luriechildrens.org

Always discuss trial participation with your own doctor first.

Locations (4)

Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois, United StatesRecruiting
C.S. Mott Children's HospitalAnn Arbor, Michigan, United StatesRecruiting
St. Louis Children's HospitalSt Louis, Missouri, United StatesRecruiting
Nationwide Children'sColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05374824